Article
Where is the evidence for cost-effectiveness of strategies to prevent or manage Candidozyma auris outbreaks in acute and non-acute settings? A systematic review of studies from high-income countries and evidence map
2026-08-04
Abstract excerpt
Background Candiozyma auris ( C. auris ) is an emerging, multidrug-resistant fungal pathogen causing severe healthcare-associated outbreaks. While the clinical and economic burdens are substantial, decision-makers in the UK face a paucity of robust economic evidence to guide resource allocation for effective infection prevention and control (IPC). Therefore, this review aimed to systematically map and synthesise...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bcc7caea-9c7a-53a3-94e2-acfa68e0598b
- DOI
- 10.3310/nihropenres.14366.1
